oral semaglutide for weight loss in non diabetics side effects IGR: New weight-loss pill beats Ozempic major trial A once-daily weight-loss pill, orforglipron, has outperformed the leading oral in a major Phase 3 clinical trial involving adults with Type Ozempic: Semaglutide is a GLP-1

New approaches for addressing muscle loss The emerging recognition of undesired muscle loss associated with incretin-based treatment of obesity as a potentially serious problem, especially in some populations, has spurred a growing interest in developing pharmacotherapies that can address this issue

More than 70% of people in the semaglutide group lost at least 10% of their body weight compared to just over 9% of people in the placebo group

Michael White, a pharmacist and researcher at the University of Connecticut in Storrs

My kids are into it

Headaches: Some individuals report headaches while taking semaglutide

While there's no harm in using it cold, many users report that injecting cold Ozempic feels sharper, more painful , or simply more uncomfortable than when it's closer to room temperature